Browsing Tag
anaphylaxis
3 posts
How EMA’s support for EURneffy 1 mg could disrupt Europe’s pediatric epinephrine market
EMA backs EURneffy 1 mg for pediatric anaphylaxis. Find out how ARS Pharmaceuticals and ALK-Abelló could reshape Europe’s allergy care landscape.
February 5, 2026
Phase 2 trial of Nasus Pharma’s NS002 needle-free epinephrine starts with initial dosing milestone
Find out how Nasus Pharma is advancing NS002, its needle-free intranasal epinephrine candidate, into Phase 2 trials and what it means for emergency allergy care.
November 18, 2025
FDA approves Genentech’s Xolair for food allergies: A new horizon in allergy treatment
The U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for reducing allergic reactions, including anaphylaxis, that…
February 17, 2024